AbbVie Operating Income 2010-2024 | ABBV

AbbVie operating income for the twelve months ending June 30, 2024 was $12.272B, a 29.41% decline year-over-year.

  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.
  • AbbVie annual operating income for 2022 was $18.117B, a 1.08% increase from 2021.
  • AbbVie annual operating income for 2021 was $17.924B, a 57.74% increase from 2020.

AbbVie Operating Income 2010-2024 | ABBV

  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.
  • AbbVie annual operating income for 2022 was $18.117B, a 1.08% increase from 2021.
  • AbbVie annual operating income for 2021 was $17.924B, a 57.74% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B